Cargando…

Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites

Aims: The current study investigates the role of diet in mediating the gut microbiome-cardiovascular association which has not yet been explored in humans. Methods and Results: Using a two-arm dietary intervention study in healthy participants (N = 70), we assessed the effects of omega-3 and fibre s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijay, Amrita, Astbury, Stuart, Panayiotis, Louca, Marques, Francine Z., Spector, Tim D., Menni, Cristina, Valdes, Ana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319029/
https://www.ncbi.nlm.nih.gov/pubmed/34336953
http://dx.doi.org/10.3389/fcvm.2021.691564
_version_ 1783730377948397568
author Vijay, Amrita
Astbury, Stuart
Panayiotis, Louca
Marques, Francine Z.
Spector, Tim D.
Menni, Cristina
Valdes, Ana M.
author_facet Vijay, Amrita
Astbury, Stuart
Panayiotis, Louca
Marques, Francine Z.
Spector, Tim D.
Menni, Cristina
Valdes, Ana M.
author_sort Vijay, Amrita
collection PubMed
description Aims: The current study investigates the role of diet in mediating the gut microbiome-cardiovascular association which has not yet been explored in humans. Methods and Results: Using a two-arm dietary intervention study in healthy participants (N = 70), we assessed the effects of omega-3 and fibre supplementation on gut microbiome composition and short-chain fatty acid (SCFA) production. We then investigated how changes in gut microbiome composition correlated with changes in traditional cardiovascular risk factors (cholesterol, triglycerides, blood pressure), cytokines, and novel validated markers such as GlycA and ceramides, previously linked to CVD incidence and mortality. Both interventions resulted in significant drops in blood pressure, cholesterol, proinflammatory cytokines, GlycA and ceramides (all P < 0.05). Decreases in the atherogenic low-density lipoprotein triglyceride fraction, in total serum cholesterol were correlated with increases in butyric acid-production [β(SE) = −0.58 (0.06), P < 0.001; −0.53 (0.04), P < 0.001] and nominally associated with increases in some butyrogenic bacteria. Drops in GlycA were linked to increases in Bifidobacterium [β(SE) = −0.32 (0.04), P = 0.02] and other SCFAs including acetic acid [β(SE) = −0.28 (0.04), P = 0.02] and propionic acid [β(SE) = −0.3 (0.04), P = 0.02]. Additionally, we report for the first-time reductions in specific ceramide ratios that have been shown to predict CVD mortality and major adverse cardiovascular events such as d18:1/16:0, d18:0/24:0, and d18:1/24:1 which were associated with the reduction in the abundance in Colinsella and increases in Bifidobacteriuim and Coprococcus 3 and SCFAs (all P < 0.05). Conclusion: Overall, these findings support the potential of using simple dietary interventions to alter validated biomarkers linked to cardiovascular risk via the gut microbiome composition and its metabolic functions.
format Online
Article
Text
id pubmed-8319029
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83190292021-07-30 Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites Vijay, Amrita Astbury, Stuart Panayiotis, Louca Marques, Francine Z. Spector, Tim D. Menni, Cristina Valdes, Ana M. Front Cardiovasc Med Cardiovascular Medicine Aims: The current study investigates the role of diet in mediating the gut microbiome-cardiovascular association which has not yet been explored in humans. Methods and Results: Using a two-arm dietary intervention study in healthy participants (N = 70), we assessed the effects of omega-3 and fibre supplementation on gut microbiome composition and short-chain fatty acid (SCFA) production. We then investigated how changes in gut microbiome composition correlated with changes in traditional cardiovascular risk factors (cholesterol, triglycerides, blood pressure), cytokines, and novel validated markers such as GlycA and ceramides, previously linked to CVD incidence and mortality. Both interventions resulted in significant drops in blood pressure, cholesterol, proinflammatory cytokines, GlycA and ceramides (all P < 0.05). Decreases in the atherogenic low-density lipoprotein triglyceride fraction, in total serum cholesterol were correlated with increases in butyric acid-production [β(SE) = −0.58 (0.06), P < 0.001; −0.53 (0.04), P < 0.001] and nominally associated with increases in some butyrogenic bacteria. Drops in GlycA were linked to increases in Bifidobacterium [β(SE) = −0.32 (0.04), P = 0.02] and other SCFAs including acetic acid [β(SE) = −0.28 (0.04), P = 0.02] and propionic acid [β(SE) = −0.3 (0.04), P = 0.02]. Additionally, we report for the first-time reductions in specific ceramide ratios that have been shown to predict CVD mortality and major adverse cardiovascular events such as d18:1/16:0, d18:0/24:0, and d18:1/24:1 which were associated with the reduction in the abundance in Colinsella and increases in Bifidobacteriuim and Coprococcus 3 and SCFAs (all P < 0.05). Conclusion: Overall, these findings support the potential of using simple dietary interventions to alter validated biomarkers linked to cardiovascular risk via the gut microbiome composition and its metabolic functions. Frontiers Media S.A. 2021-07-14 /pmc/articles/PMC8319029/ /pubmed/34336953 http://dx.doi.org/10.3389/fcvm.2021.691564 Text en Copyright © 2021 Vijay, Astbury, Panayiotis, Marques, Spector, Menni and Valdes. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Vijay, Amrita
Astbury, Stuart
Panayiotis, Louca
Marques, Francine Z.
Spector, Tim D.
Menni, Cristina
Valdes, Ana M.
Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
title Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
title_full Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
title_fullStr Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
title_full_unstemmed Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
title_short Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
title_sort dietary interventions reduce traditional and novel cardiovascular risk markers by altering the gut microbiome and their metabolites
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319029/
https://www.ncbi.nlm.nih.gov/pubmed/34336953
http://dx.doi.org/10.3389/fcvm.2021.691564
work_keys_str_mv AT vijayamrita dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites
AT astburystuart dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites
AT panayiotislouca dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites
AT marquesfrancinez dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites
AT spectortimd dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites
AT mennicristina dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites
AT valdesanam dietaryinterventionsreducetraditionalandnovelcardiovascularriskmarkersbyalteringthegutmicrobiomeandtheirmetabolites